Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 17, 2011
Bacterin International Holdings, Inc.
| (Exact Name of Registrant as Specified in Its Charter) |
| Delaware |
| (State or Other Jurisdiction of Incorporation) |
| |
001-34951
|
20-5313323
|
| |
(Commission File Number)
|
(IRS Employer Identification No.)
|
| |
600 Cruiser Lane
Belgrade, Montana
|
59714
|
| |
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
(406) 388-0480
|
|
(Registrant’s Telephone Number, Including Area Code)
|
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
ITEM 5.02
|
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
|
We provided our VP of National Sales, Robert Taggart, with 90 days notice of termination on November 17, 2011 and Mr. Taggart’s last day of employment will be February 15, 2012.
|
ITEM 7.01
|
Regulation FD Disclosure.
|
The Company has reiterated revenue guidance in the range of $30 to 32 million for 2011 and $53 to 56 million for 2012. This revenue guidance is a forward looking statement, which is subject to various assumptions, risks and uncertainties. The Company believes that its expectations, as expressed in this forward looking statement, are based on reasonable assumptions regarding the risks and uncertainties inherent in achieving those expectations. This statement is not, however, a guarantee of performance and actual results may differ materially. Risks and uncertainties which may cause actual results to be different than expressed or implied in our forward-looking statements include, but are not limited to, the risk factors described under the heading “Risk Factors” in our Annual Report on Form 10-K filed April 11, 2011. The Company expressly disclaims any current intention to update any forward-looking statement as a result of new information or future events or developments. The information in this Item 7.01 is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), nor otherwise subject to the liabilities of that section, nor incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: November 21, 2011 |
BACTERIN INTERNATIONAL HOLDINGS, INC. |
|
| |
|
|
|
|
|
By:
|
/s/ Guy S. Cook |
|
| |
|
Name: Guy S. Cook
|
|
| |
|
Title: President and Chief Executive Officer
|
|
| |
|
|
|